Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Upper respiratory tract

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

  • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).


    The EU Clinical Trials Register currently displays   44294   clinical trials with a EudraCT protocol, of which   7351   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    207 result(s) found for: Upper respiratory tract. Displaying page 1 of 11.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2006-002980-17 Sponsor Protocol Number: BV-2005/01 PRIMES Start Date*: 2007-07-12
    Sponsor Name:OM PHARMA
    Full Title: Double-blind, placebo-controlled, randomised clinical study of Broncho-Vaxom® in children suffering from recurrent upper respiratory tract infections
    Medical condition: Recurrent upper respiratory tract infections in children
    Disease: Version SOC Term Classification Code Term Level
    9.1 10046306 Upper respiratory tract infection LLT
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: HU (Completed) BE (Completed) CZ (Completed) AT (Completed) IT (Completed) SK (Completed)
    Trial results: View results
    EudraCT Number: 2010-021422-35 Sponsor Protocol Number: 09-NI-EP-001 Start Date*: 2010-10-26
    Sponsor Name:Deutsche Homöopathie-Union, DHU-Arzneimittel GmbH & Co. KG
    Full Title: Efficacy, safety and tolerability of Influcid tablets in patients (1 to 65 years old) suffering from upper respiratory tract infections with flu-like symptoms. A randomized, international, multicen...
    Medical condition: Diagnosed upper respiratory tract infection (URTI) with presence of the following symptoms for equal or less than for 24 hours : a)Fever (axillary temperature >= 37.5°C) and b)At least one upper ...
    Disease: Version SOC Term Classification Code Term Level
    12.1 10046734 URTI (upper respiratory tract infection) LLT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2013-001760-31 Sponsor Protocol Number: J0022XST302 Start Date*: 2013-07-04
    Sponsor Name:PIERRE FABRE MEDICAMENT
    Full Title: Clinical efficacy and safety of J022X ST in the prevention of Recurrent Upper-Respiratory Tract Infections (RURTI) in children with a high risk of recurrence
    Medical condition: Recurrent Upper-Respiratory Tract Infections (RURTI)
    Disease: Version SOC Term Classification Code Term Level
    17.0 10021881 - Infections and infestations 10046306 Upper respiratory tract infection PT
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: IT (Completed) LT (Completed) PL (Completed) RO (Completed)
    Trial results: View results
    EudraCT Number: 2005-000973-24 Sponsor Protocol Number: EK-NM-01-05 Start Date*: 2005-06-14
    Sponsor Name:ERREKAPPA EUROTERAPICI
    Full Title: Nimesulide spray in the treatment of simpthomatic inflammation with pain of the oral cavity (faringitis, stomatitis, pharyngitis) pre e post dental extraction. Randomised controlled vs active drug...
    Medical condition: DISEASES OF UPPER RESPIRATORY TRACT (GINGIVITIS; PHARYNGITIS; STOMATITIS)
    Disease: Version SOC Term Classification Code Term Level
    6.1 10062352 PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2016-002705-19 Sponsor Protocol Number: OMPeR Start Date*: Information not available in EudraCT
    Sponsor Name:FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO
    Full Title: A phase IV, randomized, controlled, double-blind study on efficacy and safety of OM-85 in children with recurrent respiratory tract infections
    Medical condition: Recurrent Respiratory Tract Infection
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004862 10039249 RTI LLT
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2020-001882-36 Sponsor Protocol Number: ACHIEVE Start Date*: 2020-05-07
    Sponsor Name:Hellenic Institute for the Study of Sepsis
    Full Title: ANTI-INFLAMMATORY CLARITHROMYCIN TO IMPROVE SARS-CoV-2 (COVID-19) INFECTION EARLY: THE ACHIEVE OPEN-LABEL NON-RANDOMIZED CLINICAL TRIAL
    Medical condition: Management of infection by SARS-CoV-2 (COVID-19)
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004862 10035738 Pneumonia viral NOS LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2020-001325-31 Sponsor Protocol Number: NL73551.091.20 Start Date*: 2020-05-20
    Sponsor Name:Radboud University Medical Center
    Full Title: [68Ga]Ga-DOTA-(RGD)2 PET/CT imaging of activated endothelium in lung parenchyma of COVID-19 patients.
    Medical condition: Maximum 10 patients from the Infectious Diseases ward with proven COVID-19 infection and pulmonary abnormalities on contrast-enhanced CT undergo static PET scans after injection of 70 μg (200 MBq) ...
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004855 10047468 Viral lower respiratory tract infections HLT
    20.1 100000004855 10047483 Viral upper respiratory tract infections HLT
    21.1 100000004855 10038701 Respiratory insufficiency LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: View results
    EudraCT Number: 2017-000472-28 Sponsor Protocol Number: MK-7264-013 Start Date*: 2018-06-01
    Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
    Full Title: A Phase 2a, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of MK-7264 on Acute Cough in Participants with Induced Viral Upper Respiratory Tract Infe...
    Medical condition: Acute cough in participants with induced viral upper respiratory tract infection
    Disease: Version SOC Term Classification Code Term Level
    20.1 10021881 - Infections and infestations 10047482 Viral upper respiratory tract infection PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2011-005187-25 Sponsor Protocol Number: BUC-SI-11-001 Start Date*: 2012-05-31
    Sponsor Name:SOCIETA' LABORATORIO FARMACEUTICO S.I.T. SRL
    Full Title: Efficacy and tolerability clinical trial of an immunostimulant made from inactivated bacteria (BUCCALIN) in the prophylaxis of infection of the airways (rhinotracheobronchitis, colds). Double-blind...
    Medical condition: Episodes classified by upper respiratory infections (otitis, tonsillitis, sinusitis, pharyngotonsillitis, nasopharyngitis) and lower respiratory tract (bronchitis, pneumonia).
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10060693 Respiratory tract infection bacterial PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2012-000057-31 Sponsor Protocol Number: ESTUAR001 Start Date*: 2012-03-19
    Sponsor Name:THERANOR sprl
    Full Title: Multicentre, randomised, double-blind, parallel, placebo-controlled study evaluating the efficacy and safety of Early Self-Treatment of viral Upper respiratory tract infections with homeopathic ora...
    Medical condition: Viral upper respiratory tract infections
    Disease: Version SOC Term Classification Code Term Level
    14.1 10018065 - General disorders and administration site conditions 10022004 Influenza like illness PT
    14.1 10021881 - Infections and infestations 10010106 Common cold LLT
    14.1 10021881 - Infections and infestations 10000938 Acute nasopharyngitis (common cold) LLT
    14.1 10021881 - Infections and infestations 10046300 Upper respiratory infection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-005576-32 Sponsor Protocol Number: Argo01-05 Start Date*: 2005-12-19
    Sponsor Name:BRACCO
    Full Title: TOLERABILITY OF A NEW FORMULATION OF ARGOTONE IN HEALTH VOLONTEERS
    Medical condition: Rhinitis and nasal congestion
    Disease: Version SOC Term Classification Code Term Level
    6.1 10047482 PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2009-011355-46 Sponsor Protocol Number: IMP13700 Start Date*: 2009-07-28
    Sponsor Name:Bayer Consumer Care AG
    Full Title: A double blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of acetylsalicylic acid combined with pseudoephedrine, compared with acetylsalicylic acid alone, and ps...
    Medical condition: Nasal congestion and pain associated with viral upper respiratory tract infection
    Disease: Version SOC Term Classification Code Term Level
    9.1 10046308 Upper respiratory tract infection viral NOS LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2020-001345-38 Sponsor Protocol Number: UNIKINON-01/HOPE Start Date*: 2020-04-02
    Sponsor Name:Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.
    Full Title: CHROLOQUINE PHOSPHATE AGAINST INFECTION BY THE NOVEL CORONAVIRUS SARS-CoV-2 (COVID-19): THE HOPE OPEN-LABEL, NON-RANDOMIZED CLINICAL TRIAL
    Medical condition: Possible prevention of pneumonia from SARS-CoV-2 in patients staying home and improving symptoms of SARS-CoV-2 pneumonia in patients treated in hospital
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004862 10035738 Pneumonia viral NOS LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GR (Completed)
    Trial results: View results
    EudraCT Number: 2016-000979-24 Sponsor Protocol Number: DSIT-2015-02 Start Date*: 2016-07-06
    Sponsor Name:Daiichi Sankyo Italia SpA
    Full Title: Randomized, prospective double-blind placebo controlled study for the evaluation of the number, duration and severity of Upper Respiratory Tract Infections in children with risk of recurrence after...
    Medical condition: upper respiratory tract infections in children at high risk of reccurence.
    Disease:
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2014-002474-36 Sponsor Protocol Number: GS-US-218-0108 Start Date*: 2014-11-24
    Sponsor Name:Gilead Sciences, Inc.
    Full Title: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Multi-Center Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of GS-5806 in Hematopoietic Cell Transplant (HCT...
    Medical condition: Respiratory Syncytial Virus (RSV) Infection of the upper respiratory tract.
    Disease: Version SOC Term Classification Code Term Level
    18.0 100000004862 10039247 RSV infection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed) DE (Completed) GB (Completed) NL (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2013-001958-10 Sponsor Protocol Number: IMUNOR-201301 Start Date*: 2013-09-04
    Sponsor Name:ImunomedicA, a.s.
    Full Title: A Prospective, Randomized, Double-Blind, Placebo-controlled, Multicenter, Phase III Confirmatory Study Assessing Efficacy and Safety of the IMUNOR Therapy Versus Placebo in Children with Recurrent ...
    Medical condition: Recurrent Respiratory Tract Infections
    Disease: Version SOC Term Classification Code Term Level
    16.0 10042613 - Surgical and medical procedures 10067473 Immunomodulatory therapy PT
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: SK (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2022-003855-32 Sponsor Protocol Number: KI-PROLIFIC-2023 Start Date*: 2023-03-30
    Sponsor Name:Karolinska Institutet
    Full Title: An Interventional, Double-Blinded, 2-Arm Study to Investigate the Efficacy of Orally Administered Nirmatrelvir/Ritonavir Compared With Placebo/Ritanovir in Non-hospitalized Adult Participants suffe...
    Medical condition: Patients with Post-Acute COVID syndrome (PACS) in which extensive clinical and biochemical examinations have been performed. PACS patients experience a wide variety of symptoms related to physical...
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004855 10047483 Viral upper respiratory tract infections HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-004363-34 Sponsor Protocol Number: MB 0704/1707/03 Start Date*: 2006-03-30
    Sponsor Name:VALEAS
    Full Title: Antibiotic therapy in children for the upper respiratory tract infections. Study of the ''tollerability profile'' of cefaclor and amoxicillin-clavulanate
    Medical condition: Pharyngitis, Pharyngotonsillitis or Sinusitis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10057868 Upper respiratory tract infection bacterial LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2014-002475-29 Sponsor Protocol Number: GS-US-218-1502 Start Date*: 2015-02-10
    Sponsor Name:Gilead Sciences, Inc.
    Full Title: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Multi-Center Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of GS-5806 in Hematopoietic Cell Transplant (HCT...
    Medical condition: Respiratory Syncytial Virus (RSV) Infection of the lower respiratory tract.
    Disease: Version SOC Term Classification Code Term Level
    19.0 100000004862 10039247 RSV infection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2019-000242-35 Sponsor Protocol Number: 18CT0003 Start Date*: Information not available in EudraCT
    Sponsor Name:E-Pharma Trento SpA
    Full Title: Randomized, double blind, double dummy, parallel-groups, clinical trial on efficacy and safety of ibuprofen/N-acetylcysteine fixed dose combination vs. individual components (ibuprofen and N-acetyl...
    Medical condition: symptomatic non-complicated upper respiratory tract infections
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004862 10046309 Upper respiratory tract infections HLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA